Understanding Your TNBC Journey with Clarity
LumiTNBC uses advanced AI to identify your Triple-Negative Breast Cancer molecular subtype and connect you with relevant clinical trials, with explanations you can understand.
Identify Your TNBC Subtype
Accurate molecular classification using machine learning analysis of your genomic data.
Understand the Results
Clear explanations of how your subtype was determined and what it means for your care.
Find Relevant Trials
Personalised clinical trial recommendations based on your specific TNBC molecular profile.